ELECTROCARDIOGRAPHIC DIAGNOSIS OF REPERFUSION DURING THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION

被引：65

作者：

DOEVENDANS, PA ^{[1
]}

GORGELS, AP ^{[1
]}

VANDERZEE, R ^{[1
]}

PARTOUNS, J ^{[1
]}

BAR, FW ^{[1
]}

WELLENS, HJJ ^{[1
]}

机构：

[1] UNIV LIMBURG,ACAD HOSP MAASTRICHT,CARDIOVASC RES INST,DEPT CARDIOL,6202 AZ MAASTRICHT,NETHERLANDS

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1995年 / 75卷 / 17期

关键词：

D O I：

10.1016/S0002-9149(99)80763-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Continuous 12-lead electrocardiographic monitoring was performed in 61 patients receiving thrombolytic therapy for an acute myocardial infarction. Coronary angiography within 90 minutes revealed a patent vessel (Thrombolysis in Myocardial Infarction [TIMI] trial 2 or 3) in 44 patients. Early signs of reperfusion were ST-segment normalization (likelihood ratio 16.0), development of terminal T-wave inversion (likelihood ratio 10.6), accelerated idioventricular rhythm (likelihood ratio 6.0), and a twofold increase in ventricular premature complexes (likelihood ratio 2.5). Relief of chest pain after 60 minutes was reported by 96%. During reperfusion of the infarct-related vessel, an increase in ST-segment deviation was recorded in 61% of the patients, whereas 69% had an increase in chest pain preceding the eventual decline.

引用

页码：1206 / 1210

页数：5

共 18 条

[1]

Krucoff, Green, Satler, Miller, Pallas, Kent, Del Negro, Pearle, Fletcher, Rackley, Noninvasive detection of coronary artery patency using continuous ST-segment monitoring, Am J Cardiol, 57, pp. 916-922, (1986)

[2]

Nicolau, Lorga, Garzon, Jacob, Machado, Bellini, Greco, Marques, Braile, Clinical and laboratory signs of reperfusion: are they reliable?, Int J Cardiol, 25, pp. 313-320, (1989)

[3]

Goldberg, Greenspon, Urban, Muza, Berger, Walinsky, Maroko, Reperfusion arrhythmia: a marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction, Am Heart J, 105, pp. 26-32, (1983)

[4]

Van der Laarse, Vermeer, Hermens, Willems, De Neef, Simoons, Serruys, Res, Verheugt, Krauss, Bar, de Zwaan, Lubsen, Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and enzyme release rate: a randomized trial of 533 patients with acute myocardial infarction, Am Heart J, 112, pp. 672-683, (1986)

[5]

Bar, Vermeer, de Zwaan, Ramentol, Braat, Simoons, Hermens, van der Laarse, Verheugt, Krauss, Wellens, Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction, The American Journal of Cardiology, 59, pp. 6-13, (1987)

[6]

Chesebro, Knatterud, Roberts, Borer, Cohen, Dalen, Dodge, Francis, Thrombolysis in Myocardial Infarction (TIMI) trial, phase 1: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase, Circulation, 76, pp. 142-154, (1987)

[7]

Zehender, Utzolino, Furtwangler, Kasper, Meinertz, Just, Time course and interrelation of reperfusion-induced ST changes and ventricular arrhythmias in acute myocardial infarction, Am J Cardiol, 68, pp. 1138-1142, (1991)

[8]

Hohnloser, Zabel, Kasper, Meinertz, Just, Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers, J Am Coll Cardiol, 18, pp. 44-49, (1991)

[9]

Barbash, Roth, Hod, Miller, Rath, Har-Zahav, Modan, Seligsohn, Battler, Kaplinsky, Rabinowitz, Laniado, Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction, Br Heart J, 64, pp. 241-247, (1990)

[10]

Shah, Cercek, Lew, Ganz, Angiographic validation of bedside markers of reperfusion, J Am Coll Cardiol, 21, pp. 55-61, (1993)

← 1 2 →